Skip to main content
SpringerLink
Log in

Top 10 Recent Developments in Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus

  • SYSTEMIC LUPUS ERYTHEMATOSUS (M PETRI, SECTION EDITOR)
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that has major implications for health-related quality of life (HRQoL). Improvements in the monitoring and management of SLE improves survival; however, improvement of HRQoL remains of paramount importance among these patients. Measurement of HRQoL has been recommended in clinical practice and research including drug development and testing in clinical trials. Both generic and disease specific instruments have been developed to ascertain HRQoL. In an increasingly global collaborative environment, the importance of assessing HRQoL across nations, acknowledgment of their confounders, and limitations of used instruments are critical. Here, we review selected major developments in the past 5 years highlighting: the importance of measuring HRQoL in SLE patients, the benefits and limitations of instruments that exist, and their application in research settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65.

    Article  PubMed  CAS  Google Scholar 

  2. Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008;35(11):2152–8.

    Article  PubMed  Google Scholar 

  3. Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol. 2005;32(9):1706–8.

    PubMed  Google Scholar 

  4. Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Gladman D, et al. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheumatol. 1999;26(2):504–7.

    PubMed  CAS  Google Scholar 

  5. FDA Guidance on Patient Reported Outcomes. “http://wwwfdagov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282pdf” [Internet]. 2010.

  6. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Endpoints: consensus recommendations from OMERACT IV. Outcome measures in rheumatology. Lupus. 2000;9(5):322–7.

    Article  PubMed  CAS  Google Scholar 

  7. Alarcon GS, McGwin Jr G, Uribe A, Friedman AW, Roseman JM, Fessler BJ, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA).XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004;51(3):465–74.

    Article  PubMed  Google Scholar 

  8. McElhone K, Abbott J, Gray J, Williams A, Teh LS. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus. 2010;14:1640–7.

    Article  Google Scholar 

  9. Jolly M, Utset TO. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004;13(12):924–6.

    Article  PubMed  CAS  Google Scholar 

  10. Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis. 2009;68(2):196–200. Erratum appears in Ann Rheum Dis. 2011 Aug;70(8):1519.

    Article  PubMed  CAS  Google Scholar 

  11. Zhu TY, Tam LS, Lee VW, Lee KK, Li EK. Relationship between flare and health-related quality of life in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(3):568–73.

    Article  PubMed  Google Scholar 

  12. Julian LJ, Yelin E, Yazdany J, Panopalis P, Trupin L, Criswell LA, et al. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum. 2009;61(2):240–6.

    Article  PubMed  Google Scholar 

  13. Stamm TA, Bauernfeind B, Coenen M, Feierl E, Mathis M, Stucki G, et al. Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health status. Arthritis Rheum. 2007;57(7):1287–95.

    Article  PubMed  Google Scholar 

  14. • Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semi Arthritis Rheum. 2012;42(1):56–65. This article describes the development, reliabililty and validity of LupusPRO; a disease-targeted patient-reported health outcome tool.

    Article  Google Scholar 

  15. Burckhardt CS, Archenholtz B, Bjelle A. Quality of life of women with systemic lupus erythematosus: a comparison with women with rheumatoid arthritis. J Rheumatol. 1993;20(6):977–81.

    PubMed  CAS  Google Scholar 

  16. Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, et al. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009;36(6):1209–16.

    Article  PubMed  Google Scholar 

  17. Kuriya BGD, Ibañez D, Urowitz MB. Quality of Life over time in patients with systemic Lupus Erythematosus. Arthritis Rheum. 2008;59(2):181–5.

    Article  PubMed  Google Scholar 

  18. Harrison MJ, Ahmad Y, Haque S, Dale N, Teh LS, Snowden N, et al. Construct and criterion validity of the short form-6D utility measure in patients with systemic lupus erythematosus. J Rheumatol. 2012;39(4):735–42.

    Article  PubMed  CAS  Google Scholar 

  19. Yazdany J. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res. 2011;63 Suppl 11:S413–9. Review.

    Article  Google Scholar 

  20. • Castelino M, Abbott J, McElhone K, LS T. Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature. Rheumatology (Oxford). 2013;52(4):684–96. This article compares the psychometric properties of different HRQoL questionnaires.

  21. Ow YLM, Thumboo J, Cella D, Cheung YB, Yong Fong K, Wee HL. Domains of health-related quality of life important and relevant to multiethnic English-speaking Asian systemic lupus erythematosus patients: a focus group study. Arthritis Care Res. 2011;63(6):899–908.

    Article  Google Scholar 

  22. Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, Teh CL, et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology. 2005;44(10):1267–76.

    Article  PubMed  CAS  Google Scholar 

  23. Body Image: A handbook of theory, Research, & Clinical Practice. NY: Guilford Press; 2002, 2002.

  24. Jolly M, Pickard AS, Mikolaitis RA, et al. Body image in patients with systemic Lupus Erythematosus. Int J Behav Med. 2012;19(2):157–64.

    Article  PubMed  Google Scholar 

  25. Toloza SM, Jolly M, Alarcon GS. Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues. Curr Rheumatol Rep. 2010;12(4):237–49. Review.

    Article  PubMed  Google Scholar 

  26. Jolly M, Cornejo J, Mikolaitis RA, JA B. LupusPRO and responsiveness to changes in health status and disease activity over time. Arthritis Rheum. 2011;63(10s):S898-S.

  27. Jolly M, Kosinski M, SM T, al e. Equivalence of various language versions of Lupus Specific Patient Reported Outcome Measure: LupusPRO. Arthritis & Rheum. 2012;4(10):S607-S.

    Google Scholar 

  28. Jolly M, Block JA, RA M, al e. Spanish LupusPRO: cross cultural validation study for lupus. Arthritis & Rheumatism. 2011;63(10s):S725.

  29. Salvador M, Tananguan RM, Jolly M, Navarra SV. Validation of the Filipino version of LupusPro(R) questionnaire among Filipino patients with systemic lupus erythematosus: APLAR-0471. Int J Rheum Dis. 2013;16(Supplement 1):82. Abstract.

    Google Scholar 

  30. Navarra SV, Tanangunan RM, Mikolaitis-Preuss RA, Kosinski M, Block JA, Jolly M. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines. Lupus. 2013;22(3):262–7.

    Article  PubMed  CAS  Google Scholar 

  31. Bourre-Tessier J, Clarke AE, Mikolaitis-Preuss RA, Kosinski M, Bernatsky S, Block JA, et al. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic Lupus Erythematosus in Canada. J Rheumatol. 2013;40(8):1327–33.

    Article  PubMed  Google Scholar 

  32. Bourré-Tessier J, Clarke AE, Mikolaitis-Preuss RA, Kosinski M, Block JA, M J. Validation of French version of LupusPRO among Canadian Lupus patients. Arthritis & Rheumatism. 2012;64(10s):S947-S.

  33. Kaya A, Goker B, Cura ES, Tezcan ME, Tufan A, al e. Turkish lupusPRO: cross-cultural validation study for lupus. Clin Rheumatol 2013 Aug 11[Epub ahead of print]. 2013.

  34. Jolly M, Kosinski M, Garris CP, et al. Development of the Lupus Impact Tracker: a tool for patients and physicians to assess and monitor the impact of systemic lupus erythematosus. Value Health. 2011;14(3):A 65–A6. Abstract.

    Google Scholar 

  35. Jolly M, Kosinski M, Garris CP, Ogelsby A. Validation of the Lupus Impact Tracker (LIT), a patient reported outcome tool, in a prospective multicenter longitudinal study of systemic lupus erythematosus patients. Value Health. 2012;15(7):A 515.

    Article  Google Scholar 

  36. Jolly M, Kosinski M, Garris CP. Validation of the Lupus Tracker. Value in Health. Value Health. 2011;14(3):A 65.

    Google Scholar 

  37. Jolly M, Pickard AS, Sequeira W, Wallace DJ, Solem CT, et al. A brief assessment tool for body image in systemic lupus erythematosus. Body Image. 2012;9(2):279–84.

    Article  PubMed  Google Scholar 

  38. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007;57(6):972–9.

    Article  PubMed  Google Scholar 

  39. Moorthy LN, Peterson MG, Baratelli MJ, al e. Preliminary cross-cultural adaptation of a new pediatric health-related quality of life scale in children with systemic lupus erythematosus: an international effort. Lupus. 2010. p. 83–8.

  40. • Kasitanon N, Wangkaew S, Puntana S, Sukitawut W, Leong KP, TTSHLS Group, et al. The reliability, validity and responsiveness of the Thai version of Systemic Lupus Erythematosus quality of life (SLEQOL-TH) instrument. Lupus. 2013;22(3):289–96. This article highlights the psychometric properties of the Thai version of SLEQOL-TH questionnaire.

    Article  PubMed  CAS  Google Scholar 

  41. Kong KO, Ho HJ, Howe HS, Thong BY, Lian TY, Chng HH, et al. Cross-cultural adaptation of the systemic Lupus Erythematosus quality of life questionnaire into Chinese. Arthritis Rheum. 2007;57(6):980–5.

    Article  PubMed  Google Scholar 

  42. Freire EA, Bruscato A, Leite DR, Sousa TT, Ciconelli RM. Translation into Brazilian Portuguese, cultural adaptation and validatation of the systemic lupus erythematosus quality of life questionnaire (SLEQOL). Acta Reumatologica Portuguesa. 2010;35(3):334–9.

    PubMed  Google Scholar 

  43. Jolly M, Pickard AS, Wilke C, Mikolaitis RA, Teh LS, McElhone K, et al. Lupus-specific health outcome measure for US patients: the LupusQoL-US version. Ann Rheum Dis. 2009;69:29–33.

    Article  Google Scholar 

  44. Gonzalez-Rodriguez V, Peralta-Ramirez MI, Navarrete-Navarrete N, Callejas-Rubio JL, Santos Ruiz AM, Khamashta M. Adaptation and validation of the Spanish version of a disease-specific quality of life measure in patients with systemic lupus erythematosus: the Lupus quality of life. Med Clin. 2010;134(1):13–6. Spanish.

    Article  Google Scholar 

  45. Devilliers H, Amoura Z, Besancenot JF, Bonnotte B, Pasquali JL, Wahl D, et al. LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus. Rheumatology. 2012;51(10):1906–15.

    Article  PubMed  Google Scholar 

  46. Jolly M, Toloza S, Block J, Mikolaitis R, Kosinski M, Wallace D, et al. Spanish LupusPRO: cross-cultural validation study for lupus. Lupus. 2013;22(5):431–6.

    Article  PubMed  CAS  Google Scholar 

  47. Moldovan I, Katsaros E, Carr FN, Cooray D, Torralba K, Shinada S, et al. The patient reported outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus. 2011;12:1285–92.

    Article  Google Scholar 

  48. Carr FN, Nicassio PM, Ishimori ML, Moldovan I, Katsaros E, Torralba K, et al. Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 2011;20(1):80–4.

    Article  PubMed  CAS  Google Scholar 

  49. Choi ST, Kang JI, Park IH, Lee YW, Song JS, Park YB, et al. Subscale analysis of quality of life in patients with systemic lupus erythematosus: association with depression, fatigue, disease activity and damage. Clin Exp Rheumatol. 2012;30(5):665–72.

    PubMed  Google Scholar 

  50. Kulczycka L, Sysa-Jedrzejowska A, Robak E. Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations. Clin Rheumatol. 2010;29(9):991–7.

    Article  PubMed  Google Scholar 

  51. Daleboudt GM, Broadbent E, Berger SP, Kaptein AA. Illness perceptions in patients with systemic lupus erythematosus and proliferative lupus nephritis. Lupus. 2011;3:290–8.

    Article  Google Scholar 

  52. Appenzeller S, Clarke AE, Panopalis P, Joseph L, St Pierre Y, Li T. The relationship between renal activity and quality of life in systemic lupus erythematosus. J Rheumatol. 2009;36(5):947–52.

    Article  PubMed  Google Scholar 

  53. Hyphantis T, Palieraki K, Voulgari PV, Tsifetaki N, Drosos AA. Coping with health-stressors and defence styles associated with health-related quality of life in patients with systemic lupus erythematosus. Lupus. 2011;9:893–903.

    Article  Google Scholar 

  54. McElhone K, Castelino M, Abbott J, Bruce IN, Ahmad Y, Shelmerdine J, et al. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(11):2273–9.

    Article  PubMed  Google Scholar 

  55. Jolly M, Pickard SA, Mikolaitis RA, Rodby RA, Sequeira W, Block JA. LupusQoL-US benchmarks for US patients with systemic lupus erythematosus. J Rheumatol. 2010;37(9):1828–33.

    Article  PubMed  Google Scholar 

  56. Jolly M, Kazmi N, Mikolaitis RA, Sequeira W, JA B. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures. J Am Acad Dermatol. 2012.

  57. Navarrete-Navarrete N, Peralta-Ramírez MI, Sabio-Sánchez JM, et al. Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom. 2010;79(2):107–15.

    Article  PubMed  CAS  Google Scholar 

  58. Abrahao MI, Montenegro-Rodrigues R, Marangoni RG. et al. Impact of physical activity program in systemic Lupus Erythematosus. Arthritis & Rheum. 2009;60(10 S):1123-.

    Google Scholar 

  59. Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzova D, et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 2011;63(12):3918–30.

    Article  PubMed  CAS  Google Scholar 

  60. Hartkamp A, Geenen R, Godaert GL, Bijl M, Bijlsma JW, Derksen RH. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Ann Rheum Dis. 2010;69(6):1144–7.

    Article  PubMed  CAS  Google Scholar 

  61. Griffiths B, Emery P, Ryan V, Isenberg D, Akil M, Thompson R, et al. The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE. Rheumatology. 2010;49(4):723–32. Erratum appears in Rheumatology (Oxford). 2011 Mar;50(3):634.

    Article  PubMed  CAS  Google Scholar 

  62. Jolly M, Sandler DS, Sequeira W, Block JA. Hydroxy-Chloroquine Use and Disease Specific Health Related Quality of Life in Systemic Lupus Erythematosus. Arthritis Rheum. 2010;60(10s):S108.

    Google Scholar 

  63. Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010;62(1):222–33.

    Article  PubMed  CAS  Google Scholar 

  64. van Vollenhoven RF, Petri MA, Cervera R, Roth DA, Ji BN, Kleoudis CS, et al. Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Ann Rheum Dis. 2012;71(8):1343–9.

    Article  PubMed  Google Scholar 

  65. Thumboo J, Strand V. Health-related quality of life in patients with systemic lupus erythematosus: an update. Ann Acad Med Singap. 2007;36(2):115–22 [Review] [56 refs].

    PubMed  Google Scholar 

  66. Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis. 1999;58(6):379–81.

    Article  PubMed  CAS  Google Scholar 

  67. Torrente-Segarra V, Carbonell-Abello J, Castro-Oreiro S, Manresa Dominguez JM. Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S22–6.

    PubMed  CAS  Google Scholar 

  68. Hanly JG, Su L, Omisade A, Farewell VT, Fisk JD. Screening for cognitive impairment in systemic lupus erythematosus. J Rheumatol. 2012;39(7):1371–7.

    Article  PubMed  Google Scholar 

  69. Peretti CS, Peretti CR, Kozora E, Papathanassiou D, Chouinard VA, Chouinard G. Cognitive impairment in systemic lupus erythematosus women with elevated autoantibodies and normal single photon emission computerized tomography. Psychother Psychosom. 2012;81(5):276–85.

    Article  PubMed  Google Scholar 

  70. Julian LJ, Tonner C, Yelin E, Yazdany J, Trupin L, Criswell LA, et al. Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Arthritis Care Res. 2011;63(4):542–9.

    Article  Google Scholar 

  71. Jolly M, Mikolaitis RA, Shakoor N, Fogg LF, Block JA. Education, zip code-based annualized household income, and health outcomes in patients with systemic lupus erythematosus. J Rheumatol. 2010;37(6):1150–7.

    Article  PubMed  Google Scholar 

  72. Dua AB, Aggarwal R, Mikolaitis RA, Sequeira W, Block JA, Jolly M. Rheumatologists’ quality of care for lupus: comparison study between a university and county hospital. Arthritis Care Res. 2012;64(8):1261–4.

    Google Scholar 

  73. Bennett JK, Fuertes JN, Keitel M, Phillips R. The role of patient attachment and working alliance on patient adherence, satisfaction, and health-related quality of life in lupus treatment. Patient Educ Couns. 2011;85(1):53–9.

    Article  PubMed  Google Scholar 

  74. Zuluaga MC, Guallar-Castillon P, Lopez-Garcia E, Banegas JR, Conde-Herrera M, Olcoz-Chiva M, et al. Generic and disease-specific quality of life as a predictor of long-term mortality in heart failure. Eur J Heart Fail. 2010;12(12):1372–8.

    Article  PubMed  Google Scholar 

  75. Kanwal F, Gralnek IM, Hays RD, Zeringue A, Durazo F, Han SB, et al. Health-related quality of life predicts mortality in patients with advanced chronic liver disease. Clin Gastroenterol Hepatol. 2009;7(7):793–9.

    Article  PubMed  Google Scholar 

  76. Issa SM, Hoeks SE, Scholte op Reimer WJ, Van Gestel YR, Lenzen MJ, Verhagen HJ, et al. Health-related quality of life predicts long-term survival in patients with peripheral artery disease. Vasc Med. 2010;15(3):163–9.

    Article  PubMed  Google Scholar 

  77. Michaud K, Vera-Llonch M, Oster G. Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol. 2012;39(1):54–9.

    Article  PubMed  Google Scholar 

  78. Fernandez M, Alarcon GS, McGwin Jr G, Sanchez ML, Apte M, Vila LM, et al. Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort. Arthritis Rheum. 2007;57(6):986–92.

    Article  PubMed  Google Scholar 

  79. Lupus Applications for Android. Internet [Internet]. 2013 9/13/13 AD. Available from: http://blog.laptopmag.com/best-lupus-apps?slide=1.

  80. Healthy Tweeting. Internet [Internet]. 2013; Last accessed 09/13/2013. Available from: http://www.healthytweeting.com/.

  81. USinLUPUS. Lupus Impact Tracker. Last lvisited 12/11/12 [Internet]. 2012. Available from: http://www.usinlupus.com/content/dam/usinlupus/.

  82. Touma Z, Gladman DD, Ibanez D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic Lupus Erythematosus? J Rheumatol. 2011;38:1898–905.

    Article  PubMed  Google Scholar 

  83. Ware JE. The SF-36 Health Survey. In: B S, editor. Quality of life and pharmacoeconomics in clinical trials. Second ed. Philadelphia: Lippincott-Raven; 1996. p. 337–45.

  84. Brazier JE, Tsuchiya A, Roberts J, J B. A comparison of the EQ-5D and the SF-6D across seven patient groups. Health Economics. 2004;13:873–84.

  85. Group E. EuroQol: a new facility for the measurement of health-related quality of life. Health Pol. 1990;16:199–208.

    Article  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Anisha B. Dua has served on a national advisory board for Amgen.

Zahi Touma has received honoraria from and is a consultant for GlaxoSmithKline and Janssen Research and Development, and has received royalties from www.sledai-2k.com and www.s2k-ri.50.com.

Meenakshi Jolly holds the copyrights to LupusPRO and LIT, has served as a consultant for GlaxoSmithKline, has received grant support from GlaxoSmithKline/The Binding Site, has received honoraria from GlaxoSmithKline, has received royalties from GlaxoSmithKline and MedImmune, has received payment for development of educational presentations (including service on speakers bureaus) from GlaxoSmithKline, and has had travel/accommodations expenses covered/reimbursed by GlaxoSmithKline.

Sergio Toloza declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Allegheny Health Network, Pittsburgh, PA, USA

    Anisha B. Dua

  2. University of Toronto, Toronto, ON, Canada

    Zahi Touma

  3. Hospital San Juan Bautista, Catamarca, Argentina

    Sergio Toloza

  4. Internal Medicine, Division of Rheumatology, Rush University Medical Center, 1611 West Harrison, Suite 510, Chicago, IL, 60612, USA

    Meenakshi Jolly

Authors
  1. Anisha B. Dua
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zahi Touma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sergio Toloza
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meenakshi Jolly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meenakshi Jolly.

Additional information

This article is part of the Topical Collection on Systemic Lupus Erythematosus

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dua, A.B., Touma, Z., Toloza, S. et al. Top 10 Recent Developments in Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus. Curr Rheumatol Rep 15, 380 (2013). https://doi.org/10.1007/s11926-013-0380-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11926-013-0380-9

Keywords

Search

Navigation